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) upconverting nanoparticles with the second generation 
photosensitizer 5,10,15,20-tetra(m-hydroxyphenyl)chlorin (m-THPC, Temoporfin, 
Foscan®) for photodynamic therapy.  The synthesized nanoconstruct was capable of 
generating singlet oxygen under near-infrared excitation.  




were prepared via the thermal 
decomposition method. A post-synthesis treatment with HCl was applied to render the 
nanoparticles monodispersible in aqueous solution, as well as leaving positive charges on 
the nanoparticle’s surface for conjugating potential ligands with negative charges via 
electrostatic interaction. 
m-THPC has been modified using a bio-compatible linker 4-(bromomethyl)benzoic 
acid (BMBA), which not only facilitated the grafting of the m-THPC onto the 
nanoparticle’s surface but also induced a bathochromic shift of the most intense blue 
absorption peak (Soret band) of m-THPC which resulted in an overlap with the blue 




. The overlap is of paramount importance for the 
fluorescence resonance energy transfer from the nanoparticle to the photosensitizer. The 
 iv 
 
bathochromic shift of the Soret band has been studied using computational chemistry by 
stimulating the electronic and optical properties of m-THPC and m-THPC-MBA.  
In vitro cell viability test was carried out and the results showed the nanoconstruct 
was capable of causing cell death up to 70% under 980 nm irradiation for a period of 1 
hour. The irradiation with near-infrared light gives a deep tissue penetration and the 
approach to synthesize this nanoconstruct is very general and could be applied to prepare 
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Chapter One – Introduction 
1.1 Photodynamic Therapy 
Photodynamic therapy (PDT) is a treatment for cancer and other malignant disorders 
that has been intensively developed in recent decades. In photodynamic therapy, the 
destruction of a target tissue (localized tumor) involves the combination of light of a 
specific wavelength, oxygen and a photosensitizer (PS) [1-3]. Individually, these three 
components are harmless however when combined, the putative cytotoxic agent, singlet 
oxygen (
1
O2) is generated to induce cytotoxic reactions in the cells via apoptosis or 
necrosis, leading to the self-destruction of tumor cells. Photodynamic therapy is a 
stepwise treatment (Figure 1.1) that starts with the injection of the photosensitizer into the 
bloodstream and requires 1 to 3 days for the tumor cells to absorb the drug. Light 
exposure is then applied only to the tumor tissues to activate the photosensitizer, which 
results in the conversion of molecular oxygen to singlet oxygen that induces cell death 
and destroys the tumor tissues. 
 




Being the key component for photodynamic therapy, a number of photosensitizers 
have been developed over the years and can be divided into three generations. The first 
generation photosensitizer is the hematoporphyrin derivative (HpD) that was first 
approved in 1993 as Photofrin® in Canada for treatments of bladder cancer, lung cancer 
and esophageal cancer [4]. The second generation PS was developed with higher 
chemical purity and more defined content such as 5,10,15,20-tetra(m-
hydroxyphenyl)chlorin (m-THPC) with trade name Foscan® and generic name 
Temoporfin [5-7]. It was approved by the European Union in 2001 for the treatment of 
advanced head and neck cancer. The third generation photosensitizers with higher 
selectivity towards the target tumor tissues are currently under development [8].  
In 1989 Bonnett et al. established the requirements for an ideal photosensitizer, 
which includes lack of dark toxicity, uniform stable composition with high chemical 
purity, high selectivity towards tumor tissues over healthy cells, a triplet state energy 
greater than 94 kJ/mol with high singlet oxygen quantum yield, and the ability to absorb 
red light (above 650 nm) [9]. As a second generation photosensitizer, m-THPC was 
developed to meet the above requirements and was used to carry out all the work 
presented in this thesis. The structure of m-THPC is shown in Figure 1.2. m-THPC is 
derived from the meso-tetra(hydroxyphenyl)porphyrins (m-THPP) via a “diimide 
reduction” [10, 11] which produces a saturated bond between C17 and C18 (Figure 1.2) 
The introduction of this single bond significantly affects the absorption properties of m-
THPC. The absorption band which is used in PDT not only showed a redshift from 644 
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) [12].  
      
Figure 1.2. Chemical structure of the 5,10,15,20-tetra(m-hydroxyphenyl)chlorin (m-
THPC) and 5,10,15,20-tetra(m-hydroxyphenyl)porphyrin (m-THPP). 
With the improved absorption properties and a 100 to 200 times more potent effect 
than the first generation photosensitizers, m-THPC quickly became a favorite PDT agent 
[6]. m-THPC is a porphyrin derivative, with a characteristic UV/Vis spectrum that 
contains an intense Soret band in the 380 to 500 nm range and a group of weaker bands, 
Q-bands, in the region 500 to 750 nm. Up to now, photodynamic therapy has made use of 
red light (Q-bands) to excite the photosensitizer and generate singlet oxygen. However, 







never been used since light in this region has low tissue penetration depth.  
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1.1.2 Light in Photodynamic Therapy 
In addition to the photosensitizer, the excitation light is of paramount importance 
since the efficiency of photodynamic therapy strongly depends on the excitation 
wavelength. As previously mentioned, porphyrin-type photosensitizers such as m-THPC 
have two principal absorption, the Soret band and Q-bands. Excitation with light from 
either of these bands will provide sufficient energy to activate the photosensitizer. 
However, porphyrin-type  photosensitizers currently use red light in the Q-band region 
thus not taking advantage of the biological optical window (700 to 1000 nm) where the 
major biological components such as water (black line), hemoglobin (blue line), and 
oxyhemoglobin (red line) show their lowest absorption (Figure 1.3).  
 
Figure 1.3. Biological optical window [13, 14]. 
The ideal excitation light for efficient photodynamic therapy should be at a 
wavelength that not only activates the photosensitizer but also has deep tissue penetration 
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depth. The Soret band corresponds to the blue region of the spectrum (400 nm) and can 
only penetrate 1 mm into the biological tissue which limits its applications [15]. As the 
wavelength increases to 630 nm, which is the excitation currently used in PDT, the 
penetration depth increases to 10 mm and at a wavelength of 980 nm in the NIR region, 
the tissue penetration depth is approximately 32 mm (Figure 1.4) which would not limit 
m-THPC to the treatment of only head and neck cancer. It should be noted that the 
scattering of light varies as 1/4 [16].  
 
Figure 1.4. Tissue penetration depth of light of different wavelengths: 980 nm, 630 nm, 
and 400 nm. 
Deep tissue penetration can be obtained by making use of the optimal spectral 
biological window. Unfortunately, photons in this region are energetically too low for 
1
O2 
generation, whereas, direct excitation with high-energy blue light limits the use in 




1.2 Lanthanide-doped Upconverting Nanoparticles in Biomedical Applications 
Lanthanide-doped upconverting nanoparticles (Ln-UCNPs) have emerged as a novel 
class of luminescent probes with applications in many fields such as bio-imaging, 
diagnosis, drug delivery, and therapeutics due to the unique optical property of 
lanthanides known as upconversion [17]. These upconverting nanoparticles can emit UV, 
visible and/or NIR light upon NIR excitation, typically 980 nm, via a multiphoton 
absorption process.  
Lanthanide doped upconverting nanoparticles can be prepared following different 
synthetic routes to achieve high dispersibility in physiological environments with tunable 
sizes and emission profiles. The Ln-UCNPs exhibit low cytotoxicity, no photobleaching 
and low autofluorescence, which makes their use advantageous over quantum dots and 
organic fluorophores [18]. The Ln-UCNPs have also been proposed as a source of energy 
for exciting photosensitizers for applications in photodynamic therapy allowing 
simultaneous targeting and imaging of specific tumor cells [19-24].   
 1.3 Statement of the Problem 
The development of nanotechnology for biomedical applications is extremely 
important in the field of disease research especially those related to cancer therapy. 
Photodynamic therapy is one of the most popular therapeutic methods used in cancer 
treatment and has drawn a great amount of attention in recent years. The essential 
element in the development of PDT is the PS. Over the past decades, considerable efforts 
have been undertaken for the development of new PS, which show increased absorption 
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further in the red (beyond the standard PS absorption of max < 650 nm) enabling the use 
of light with lower degree of scattering and penetrating deep into the tissues.  
The second generation PS, 5, 10, 15, 20-tetra(m-hydroxyphenyl)chlorin (m-THPC, 
Foscan), with enhanced absorption of light in the red (max = 652 nm) has been found to 
be more specific than conventional porphyrins where skin photosensitization, usually a 
side effect, has been reported to be shorter. However, m-THPC does not make use of the 
optimal spectral biological window for tissue penetration in the 700 nm to 1m range. 
Unfortunately, photons in this region are energetically too low for 
1
O2 generation. In 
addition to the band at 652 nm, which has a high molar extinction coefficient ( = 
2.9104 cm-1M-1), m-THPC has another absorption band in the blue region centered at 
417nm with a much higher molar absorption coefficient ( = 2.3105cm-1M-1). Excitation 
of m-THPC at this wavelength would eliminate the problem of low photon energy, 
however direct excitation with high-energy blue light limits the use in biological 
applications due to its low tissue penetration depth.  




-doped LiYF4 UCNPs via the thermal 
decomposition method, which showed stronger UV/blue emission following NIR 
excitation with 980 nm light compared to NaYF4 [25]. Taking advantage of the high 
penetration depth and minimal autofluorescence of the NIR excitation light, these Ln
3+
-
UCNPs could be used as UV/blue excitation sources in biological applications. 
Incorporating m-THCP with Ln
3+
-UCNPs could achieve the excitation of m-THPC upon 
NIR excitation through a fluorescence resonance energy transfer (FRET) process.  




 UCNPs with m-
THPC to demonstrate the generation of singlet oxygen by this molecule using the blue 
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light obtained following NIR excitation of the nanoparticles. We show that in order to 
achieve the generation of singlet oxygen from the upconverted blue light emission of the 
Ln
3+
-UCNPs, it was necessary to modify the m-THPC using 4-(bromomethyl)benzoic 
acid (BMBA), which not only facilitated grafting of m-THCP onto the Ln
3+
-UCNPs but 
also induced a bathochromic shift of the blue absorption peak.  
In addition, establishing the number of methyl benzoic acid (MBA) molecules and 
their position(s) bonding to the m-THPC is essential since it will shed light on 
understanding the role, which the MBA molecules have on the spectroscopic properties 
of m-THPC. Thus, to understand the effects of the substituent and its position) we 
undertook a computational study using the Gaussian 09 program. Time-dependent 
density functional theory was combined with Becke Three Parameter Hybrid Functionals 
(B3LYP) and the basis set 6-31G(d,p) was used to optimize the ground state geometry of 
the m-THPC and m-THPC-MBA. Gouterman’s four orbital model was applied to 
calculate the absorption of m-THPC and of the m-THPC-MBA. 
In vitro cell viability tests were performed to confirm the effect of the nanoconstruct 
on the cells in the absence and presence of irradiation at 980 nm. HeLa carcinoma cells 





-UCNPs) at concentrations of 0.004 to 0.1 mg/mL in PBS. Cell viability 






Chapter Two - Theory 
2.1 Photodynamic Therapy 
2.1.1 Historical and Clinical Applications of PDT in Cancer Treatment 
The application of photodynamic therapy used to treat human diseases dates back 
3000 years by the Egyptians, the Chinese and the Indians [27]. The first “modern” 
application of photodynamic therapy was by Danish scientist Niels Rydberg Finsen, who 
was awarded the Nobel Prize in Physiology-Medicine in 1903 [28]. The Nobel 
Committee stated “in recognition of his contribution to the treatment of diseases, 
especially lupus vulgaris, with concentrated light radiation, whereby he has opened a 
new avenue for medical science”. A German student Oscar Raab working under the 
direction of von Tappeiner contributed to the early development of PDT by reporting on 
the rapid killing of paramecia by acridine or eosin but only in the presence of light and 
oxygen. In 1903, von Tappeiner and Jesionek published the first paper reporting on the 
clinical trial of PDT on patients with skin carcinoma using eosin as the photosensitizer. 
Other trials on patients by Dreyer and Neisser were terminated due to the severe side 
effects. In 1911 the use of hematoporphyrin (Hp) in mice was conducted by Walter 
Hausmann, with some success and the first injection of Hp in humans was in 1913 by 
Meyer-Betz who injected himself with the photosensitizer. It is reported that he was 
photosensitive for more than two months which showed the accumulation and retention 
of Hp in humans [29]. 
Further studies on the clinical applications of PDT resumed some 70 years later by 
Dougherty and co-workers. They made significant contributions in the study of a group 
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of photosensitizers named hematoporphyrin derivatives (HpD), and they reported the first 
case of successful treatment of tumors in experimental animals using PDT [30, 31]. The 
investigation on HpD by Dougherty and his co-workers started the modern development 
of clinical photodynamic therapy. 
2.1.2 Role of Singlet Oxygen in PDT 




, 94 (22.5 
kcal mol
-1
) and 158 kJ mol
-1
 (31.5 kcal mol
-1
) above the triplet state respectively [32]. 
The electronic configuration of these states differ only by occupancy of the -antibonding 
orbitals (Figure 2.1). The triplet ground state (
3∑-g) electronic configuration is identical to 
1∑g
+
 of the second excited state except that the last two electrons have parallel spins.  
 
Figure 2.1. Occupation of molecular orbitals in oxygen.  
The transition from the 
1Δg state to the 
3∑-g state is spin forbidden therefore the 
1Δg 
O2 is a relatively long lived species. The second excited state (
1∑g
+
) of oxygen is short 
lived since the transition to the 
1Δg is spin allowed. The difference in stability of the two 
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states is confirmed by the radiative lifetimes that have been reported for O2 (




) which are 64 min and 10 s in the gas phase respectively [33]. The two excited 
singlet states also have very different lifetimes depending on the nature of the solvent 
where the lifetime of 
1Δg state can vary from 1µs to 1 ms and for the higher energy state 
10 ps to 1 ns [34]. 
2.1.3 Mechanism of Type I and Type II Photosensitization 
There are many known sources of singlet oxygen, however we will focus on the 
photosensitized method of generation since this is the process, which is used in this 
thesis. 
Photosensitized generation of singlet oxygen is a simple process requiring oxygen, 
light of appropriate wavelength and an appropriate photosensitizer (PS) capable of 
absorbing and using the energy to excite oxygen to its singlet state.  Briefly, upon 
illumination the photosensitizer is excited, from the ground state S0 to a short lived 
excited singlet state Sn. Non-radiative relaxation (Internal Conversion) of Sn to the lowest 
excited singlet state, S1, is followed by conversion to the triplet state (T1) via intersystem 
crossing (ISC) (Figure 2.2). The triplet state has a long lifetime generally in the s to ms 
range, which enables the excited photosensitizer to react with the surrounding molecules. 
The excited triplet state of the photosensitizer may lose its energy either via radiative 
triplet-singlet emission (phosphorescence) or via quenching of the excited triplet state 
that has been shown to be the process which generates the cytotoxic agents needed to 
induce cell death. This quenching mechanism can occur via a Type I or Type II 




Figure 2.2. Jablonski diagram for the activation of photosensitizer and generation of 
singlet oxygen.  
 
 




As shown in equations 1 to 10 a Type I mechanism occurs via hydrogen atom 
extraction or electron transfer reactions between the photosensitizer’s excited state (3PS) 
and a substrate (S), biological or solvent, to produce radicals and radical ions [36]. It is 
well known that radical species are very reactive and can react with molecular oxygen to 
produce reactive oxygen species such as superoxide anion, which lead to the cytotoxic 
effects. It is worth noting that hydrogen peroxide is a moderate oxidant, however when 
accumulated it can react with superoxide radicals to produce the hydroxyl radical (HO
•-
) 
and induce various reactions that lead to the cell deaths.  
 
The mechanism for Type I reaction starts with the excitation of the ground state 
photosensitizer 
0
PS to its triplet state 
3
PS. As a direct reaction, the excited 
3
PS reacts with 
substrate (S) immediately to form neutral radicals (Eq 1 and 3) or radical ions (Eq 5 and 
7). In presence of molecular oxygen, the resulting radicals undergo reaction with oxygen 
to produce superoxide radicals or radical ions (Eq 2, 4, 6, and 8), and the very active 
peroxide radicals will then convert to hydrogen peroxide via spontaneous dismutation 




In contrast to a Type I mechanism, in a Type II mechanism 
3
PS reacts first with 
molecular oxygen to generate the reactive singlet oxygen that is responsible for the 
oxidation of the substrate. This mechanism results from an energy transfer between the 
excited triplet state of the photosensitizer and the ground state of molecular oxygen 
generating the first excited state of singlet oxygen (Figure 2.2). This mechanism requires 
the presence of molecular oxygen.  The reaction is as follow: 
                          
                         Photosensitizer          →             Photosensitizer*        
    3
Photosensitizer* + O2 (
3Σg
–)          →             Photosensitizer + O2 (
1∆g)  
                   O2 (
1∆g) + Substrate        →             Oxidative damage 
  
It is important to note that the Type II mechanism can only occur when the energy 
gap between the ground state and triplet excited state of the photosensitizer is greater than 
the energy gap between the ground state and singlet state of oxygen, which is 94 kJ/mol 
(0.98 eV) [32]. As most of the porphyrin-like molecules have energy gaps greater than 94 
kJ/mol and can be used as potential photosensitizers, thus the photosensitization in PDT 







2.2 The Lanthanides  
The lanthanoids are a group of fourteen elements that follow lanthanum in the 
periodic table with atomic number from 57 to 71. Lanthanum, which possesses many 
similar chemical and physical properties to the other members of the group, is included in 
the lanthanide family although it has been argued that it should not be considered a 
member since it lacks f-orbitals. Also included in this group are the Group III transition 
metals Y and Sc since they also have many similar properties to the lanthanides. Thus, 
with the inclusion of scandium and yttrium these elements are known as "rare-earth 
elements" which is a misnomer since these elements are quite common in the Earth’s 
crust. 
Moving along the group corresponds to the successive filling of the 4f orbitals from 
La (4f 
0
) to Lu (4f 
14




 and a summary 
of the electronic configurations is shown in Table 2.1. The common oxidation state is +3 
however some of the lanthanides may exist as +2 and +4. The trivalent lanthanide ions 
(Ln
3+
) have an electronic configuration [Xe]4f 
n
, where n goes from 0 for lanthanum to 14 




 orbitals making it 
difficult to lose a 4f electron. As a consequence the +3 oxidation state becomes the most 
stable form. Since the valence electrons are the same (4f 
n
) for all the Ln
3+
 ions, they all 












































































































































The luminescence of the Ln
3+
 ions arises from transitions within the 4f shell and 




 shells, electrons in the 4f orbitals 
have little participation in chemical bonding, and the crystal field has almost no effect on 
the energy of the levels, that is, the absorption and emission of the ions are only slightly 
affected by the environment [40]. Two other important effects arising from the shielding 
are the sharpness of the emission and absorptions lines and the very small Stokes’ shift, 
which is observed when excitation is achieved directly into the 4f levels. The forbidden 
nature of electronic intra-configurational transitions (Laporte's rule) results in weak f-f 
electric dipole transitions while the much less intense magnetic dipole transitions are 
allowed [41]. Due to j-mixing and the admixture of vibrational states, electric dipole 
transitions are observed with intensities of the same order of magnitude as the magnetic 
dipole transitions.   
The Russell-Saunders spin-orbit coupling scheme is valid for the lanthanides and the 
term symbols for the energy levels are derived using this scheme. Dieke and co-workers 
in 1950's and 1960’s carried out detailed experimental work of the lanthanide transition 
and their work resulted in the tabulation of the energy levels of the trivalent lanthanide 
ions in LaCl3 [42]. This resulted in the well-known Dieke energy level scheme shown in 









2.3 Upconversion Mechanisms 
Upconversion is a process that generates high energy UV and visible light from 
lower energy radiation such as near infrared or infrared [41, 43-46]. This multiphoton 
process involves the sequential absorption of two or more photons to populate the 
luminescent excited state (UV and visible) and it requires a metastable intermediate 
electronic state with relatively long life time located between the ground state and the 
luminescent excited state to act as a population reservoir [43]. The ideal candidates to 
perform efficient upconversion are the trivalent lanthanide in solid-state materials. The 
trivalent lanthanide ions possess three important characteristics, which makes them ideal 
candidates for upconversion. Firstly, they have sharp spectroscopic lines with high 
emission cross sections which result in efficient luminescence. Secondly, the crystal field 
splitting results in a number of intermediate levels where either energy transfer or excited 
state absorption can occur. Thirdly, the long intermediate state lifetimes makes these 
states ideal as population reservoirs from which a second photon can populate the 
emitting state.   
Upconversion occurs via three major mechanisms namely excited state absorption 
(ESA), energy transfer upconversion (ETU) and photon avalanche (PA). The first two 
mechanisms are related to the work presented in this thesis and will be explained in 
detail.   
2.3.1 Excited State Absorption (ESA) Upconversion 
Excited state absorption is the sequential absorption of two photons by a single ion 
[43, 47] shown in Figure 2.5. Ion X in the ground state (G) absorbs the first photon and 
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induces the transition to the metastable state E1 that is intermediate in energy between the 
ground sate and the fluorescing state E2. A second photon is absorbed and induces the 
transition from metastable state E1 to the upper state E2 followed by emission and 
relaxation to the ground state. The energy gaps between ground state G, the intermediate 
state E1 and higher excited state E2 should be close to the pump wavelength. 
 
Figure 2.5. Schematic representation of excited state absorption (ESA) upconversion. 
2.3.2 Energy Transfer Upconversion (ETU)  
Energy transfer upconversion occurs between a pair of neighboring ions via the 
transfer of energy between these ions where one acts as a donor and the other as an 
acceptor. The mechanism for ETU is shown in Figure 2.6. The first step is the absorption 
of an incoming pump photon by both donor ions Y, which induces a transition of the 
donor to the intermediate excited state E1. The donor ion Y usually has a high absorption 
cross section. In the second step a non-radiative energy transfer occurs from donor ion Y 
to the acceptor ion X that promotes ion X to its metastable state E1, followed by another 
energy transfer process from the donor ion Y to the acceptor ion X resulting in a 
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transition to the higher excited state E2 of the acceptor.  The donor ions Y relax to the 
ground state and the acceptor ions undergo a radiative decay from the excited state E2 to 
ground state G. It is very important that the incoming photons have the same energy as 
the energy gap separating G and E1 states, and for an efficient ETU the donor and 
acceptor ions should be in close proximity since energy transfer is dependent on the 
distance between the neighboring ions. This normally requires a donor ion concentration 
of 10-50 times that of the acceptor [43-45].  
 
 
Figure 2.6. Schematic representation of energy transfer upconversion. 
2.4 The Fluoride Host  
Nanoparticles that exhibit upconversion luminescence have been synthesized using 
various crystalline host and lanthanide dopants in order to achieve high upconversion 
efficiency and tunable emission. As mentioned previously, the lanthanide dopants acting 
as donor-acceptor pairs mainly control the emission profile due to their ladder-like energy 
levels that facilitate the energy transfer process. The choice of the host material is 
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extremely important to obtain high upconversion efficiency and high luminescence 
intensity. Numerous host materials such as oxides, garnets, vanadates, phosphates etc. 
have been synthesized and studied for potential applications in upconversion. However, 
fluoride hosts such as NaYF4, NaGdF4, and LiYF4 have been shown to be the ideal hosts 
for upconversion. Oxides and phosphates have been studied for upconversion however 
the phonon energies associated with these hosts are relatively high (>500-1000 cm
-1
) 
resulting in low upconversion efficiencies due to the enhancement of non-radiative 
transitions [17]. Phonon energy is the vibrational energy associated with the oscillation of 
atoms in solids and is non-radiative [48]. The fluoride hosts have been reported to show 
high upconversion efficiency. This has been attributed to their low phonon energies 
(~350 cm
-1
), which renders them ideal hosts for the upconversion process [25]. 
The excited states of lanthanide ions relax via two competitive pathways namely by 
light emission and phonon emission processes [49, 50]. The rate of phonon emission, ω, 
depends on the number of phonons emitted simultaneously to bridge the energy gap and 
is expressed by equation 11. 
    exp-kE/hmax) (11) 
 
where, ΔE is the energy gap to the nearest lower level and hνmax is the maximum energy 
of phonons coupled to the emitting states. The phonon emission rate, ω, decreases rapidly 
with an increase in ΔE, so that the competitive light emission or radiative process 
becomes dominant. Thus, the luminescence efficiency of an excited state is based on the 
energy gap that needs to be bridged to the next lower state. Generally, the larger is the 
number of phonons needed to convert the excitation energy into phonon energy, the 
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lower is the efficiency of the non-radiative process. Hence, to enhance the emission 
efficiency by reducing the non-radiative rate, it is desirable to have the lanthanide ions 
incorporated into a host of very low frequency phonons. Among investigated hosts, 
fluoride materials have the lowest phonon cutoff energy and generally exhibit the highest 
UC efficiency due to the minimization of non-radiative losses in the intermediate states 
or the emitting states [25].  
In addition to the low phonon energy, the local crystal field can also affect the 
upconversion. The crystal field of a host material has a profound effect of the 
upconversion efficiency of lanthanide emitters, as the local crystal symmetry surrounding 
a lanthanide ion strongly influences its optical properties. A less symmetric crystal phase 
is generally favorable for the upconversion efficiency, as the intermixing of the 





 microcrystals exhibit visible upconversion 
luminescence, which is 4.4 times higher than its cubic counterpart [51-53]. 
2.4.1 The Host LiYF4 
An ideal host material should be transparent in the spectral range of interest, have 
high optical damage threshold, be chemically stable and be associated with high 
upconversion efficiency. In this thesis LiYF4 , was chosen as the host material because it 
not only shows all of the properties mentioned above but also because it is one of the 
most efficient host materials for the upconversion process [25]. In contrast to NaYF4 host 
matrix, LiYF4 not only offers comparable emission intensity but also generates additional 
strong emission lines in the blue and UV (Figure 2.7). 
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LiYF4 is one of the best known fluorides that have a tetragonal sheelite structure in 
reference to CaWO4. Lithium ions are in the center of tetrahedra fluoride ions. Yttrium 




 can be substituted 




. LiYF4 has a high capacity for 
isomorphous replacement of yttrium ions by trivalent lanthanides without strongly 
affecting the lattice structure, due to their similar size [54]. 
 




 trivalent ions involved in ETU process. 
Possible emissions from Tm
3+




Figure 2.8. Crystal structure of LiYF4 [54]. 
2.5 Computational Approach to Study the Spectroscopic Properties of the 
Photosensitizer 
Computational chemistry is focused on obtaining results relevant to chemical 
problems not directly developing new theoretical models. Computational chemistry 
makes use of the computer as an experimental tool much like for example NMR. 
Computational chemistry is used to simulate chemical structures, reaction pathways and 
properties of molecules, which are difficult to examine using traditional experimental 
approaches. The computational simulation is based on two fundamental methods 
quantum mechanics (QM) and molecular dynamics (MD) and the former is generally 
used to study the structure and electronic properties of molecules [55, 56].  
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2.5.1 Background and Methodology  
Quantum mechanics is used in computational chemistry to calculate chemical and 
physical properties related to electronic distribution based on the time-dependent 
Schrodinger equation: 
{
   
    
    } (   )  
  
  
  (   )
  
                       (  ) 
where m is the mass of a single particle, Ψ is the wavefunction of the motion of that 
particle, h is Planck's constant, V is the potential field in which the particle is moving and 
 2 is the Laplacian operator, 
   
  
   
 
  
   
 
  
   
                                      (  ) 
In computational calculations three main classes of electronic structure methods are 
used; semi-empirical, ab initio and density functional theory (DFT) which are all based 
on the laws of quantum mechanics and use a variety of approximations to obtain the 
solution to specific problems. Semi-empirical methods use experimental parameters to 
simplify calculations and have been used extensively for organic molecules to obtain 
qualitative information or for large systems to perform preliminary optimizations prior to 
the subsequent high level calculations. Semi-empirical methods are very efficient 
methods with good accuracy and low cost, however there are limitations. The 
experimental parameters for all the atoms in the system studied must be developed due to 
its "empirical" nature. In contrast to semi-empirical methods, ab initio methods use only 
the mathematical approximations derived from the laws of quantum mechanics to 
perform calculations and obtain results with high quality however at a much higher cost 
(in computer time). To obtain high quality results and decrease the cost, density 
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functional theory methods have been developed in recent years, which have been widely 
used. The DFT and ab initio methods are similar however DFT calculations give 
significantly higher accuracy due to the inclusion in the calculation of electron correlation 
effects. When modeling a molecular system the electron correlation effects are taken into 
consideration using the kinetic energy, the electron-nuclear interaction, and the Coulomb 
repulsion separately which assumes inter-electronic interaction. This represents the 
system more accurately than the Hartree-Fock (HF) theory which considers the electron 
effect as an average.   In the DFT methods the electron correlation is computed via 
functionals of electron density and one of the best known is the hybrid exchange-
correlation functionals B3LYP (Becke's three-parameter, Lee-Yang-Parr).     
The choice of a theoretical method and functionals is the first and the most 
important step in performing a calculation on the molecular system of interest.  Another 
important component in the calculation is the basis set, a mathematical description of 
molecular orbitals using linear combinations of functions. The accuracy and cost of a 
calculation is highly dependent on the choice of basis set. A minimal basis set uses fixed-
sized atomic orbitals with minimum number of basis functions and one example is STO-
3G used in ab initio calculations in which STO stands for the Slater-type orbital and 3G 
means three Gaussian primitives are included for each basis function. For calculations 
that require a higher level of accuracy, split valence basis sets are developed in addition 
to the minimal basis sets and two or more sizes of basis function for each valence orbital 
are been included to allow orbitals to change size. For example, the set 6-31G, six 
primitives are used in each core atomic orbital basis function and the valence orbital is 
described by two basis functions that have three primitive GTOs and one primitive GTO 
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respectively. In addition to changing orbital size, polarization functions are used to allow 
orbitals to change shape by adding high angular momentum functions to valence 
electrons. As an extension to the basis set 6-31G, 6-31G(d) includes d functions for heavy 
atoms and 6-31G(d,p) includes d functions for heavy atoms plus additional p functions 
for hydrogen. For systems in which electrons are located far from the nucleus, such as 
molecules in their excited states, diffuse functions are added to the basis set to allow 
orbitals to occupy a larger region of space and yield more accurate results. The notation 
of a basis set with diffuse functions is represented by the "+" sign, 6-31+G(d) indicates a 
basis set with diffuse function on heavy atoms only and 6-31++G(d) is with diffuse 
function on both heavy atoms and hydrogen atoms.  
  2.5.2 Modeling Excited State Using TD-DFT Method  
In quantum mechanics excited states of molecular systems are the stable electronic 
configurations with energies higher than the ground state and are closely related to the 
electronic transitions and spectroscopic properties. TD-DFT is one of the more 
commonly used methods in calculating excitation energies for the excited states and has 
been found to be accurate in simulating absorption spectra of organic molecules such as 
porphyrin and chlorin [57, 58]. The four-orbital model developed by Gouterman in the 
1960s is the mostly used theoretical basis for the prediction of porphyrin UV/Vis 
absorption spectra [59, 60]. As shown in Figure 2.9 the characteristic Soret bands and Q-
bands in a typical porphyrin arise from transitions between HOMO and HOMO -1 π 
orbitals and LUMO and LUMO +1 π* orbitals. Several factors such as the conjugation 
pathway, symmetry and substituent have been shown to affect these orbitals thus leading 
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to a change in the absorption spectra [59, 61-65]. Therefore in this thesis TD-DFT has 
been applied to model the excited states of the photosensitizers m-THPC and m-THPC-
MBA for the interpretation of UV/Vis absorption spectra and understanding the effect of 
MBA linker.  
 
Figure 2.9. Energy levels of the four Gouterman orbitals and transitions that give rise to 









Chapter Three – Experimental and Characterization Techniques 





(25%) upconverting nanoparticles were synthesized 
via the thermal decomposition method established by our group [25]. The two major 
steps involved in the synthesis are the preparation of the trifluroacetate lanthanide 
precursors, and the formation of the oleate capped nanoparticles. 






 Trifluroacetate Precursors 
The lanthanide trifluoraceate precursors were prepared by dissolving 210.3 mg 
(0.931 mmol) of Y2O3, 123.2 mg (0.313 mmol) of Yb2O3 and 2.4 mg (0.00625 mmol) of 
Tm2O3 in a mixture of 5 mL of trifluoroacetic acid (CF3COOH) and 5 mL of water.  The 
reaction mixture was heated to 80 °C under reflux for 12 hours and then slowly 
evaporated to dryness at 60 °C. 





In the second step of the synthesis procedure a solution (solution A) containing 12.5 
mL of oleic acid and 12.5 mL of 1-octadecene was degassed at 150 °C for 30 min and 
then maintained at the same temperature under an argon atmosphere. CF3COOLi, 299.9 
mg (2.5 mmol) was added to the dried lanthanide precursor solids and dissolved in 7.5 
mL of oleic acid and 7.5 mL of 1-octadence (solution B). Solution B was degassed at 125 
°C under vacuum. Solution A was heated to 315 °C under a gentle flow of argon gas. 
Solution B was added to solution A using a syringe and pump system at a rate of 1.5 
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mL/min. The solution was heated under argon at 315 °C for 90 min with continuous 
stirring. The solution was allowed to cool to room temperature. Nanoparticles were 
precipitated out using ethanol (99%). The nanoparticles were isolated by centrifugation at 
4000 rpm, which is equivalent to relative centrifugal force of 1350g, for 15 min and then 
washed with ethanol/hexane (4:1) mixture twice to remove any impurities. 
3.1.3 Preparation of Water Dispersible Nanoparticles via Removal of the Capping 
Ligand Oleate 




-UCNPs are hydrophobic due to the 
hydrophobic capping ligand oleate on their surface. To render the nanoparticles 
hydrophilic and water dispersible, the capping ligand oleate was removed via a simple 
HCl treatment [66]. An appropriate amount of oleate capped Ln-UCNPs were dispersed 
in a 0.1 M solution of HCl and maintained at pH at 4 while stirring for 2 hours. During 
this reaction the carboxylate groups of the oleate ligand were protonated to produce oleic 
acid. After the reaction was completed the aqueous solution was mixed with diethyl ether 
to remove the oleic acid. The extraction with diethyl ether was carried out three times. 
The combined diethyl ether layers were re-extracted with water. The Ln-UCNPs in the 
water dispersible fraction were recuperated by centrifugation (4000 rpm) after 






3.2 Modification of Photosensitizer Temoporfin 
The photosensitizer m-THPC was modified by adding a biocompatible linker, 4-
bromomethyle benzoic acid, in order to add a carboxylate functionality, which allows for 
the functionalization to the UCNPs as well as cause a red shift of m-THPC's Soret band. 
3.2.1 Coupling Reaction between m-THPC and 4-Bromomethyl Benzoic Acid 
m-THPC was kindly provided by Biolitec AG in Germany. 4-
(Bromomethyl)benzoic acid, 97% purchased from Alfa Aesar was used as a linker to 
bond m-THPC to the Ln-UCNPs. A sodium hydride suspension in 10 mL of 
tetrahydrofuran was added to 20 mg (0.029 mmol) of m-THPC. The reaction mixture was 
heated under reflux for 30 min with stirring. 24.9 mg (0.060 mmol) of 4-
(bromomethyl)benzoic acid was added dropwise and the mixture was refluxed for 12 
hours. After cooling to room temperature water was added to the mixture and THF was 
removed under vacuum. The aqueous solution was adjusted to pH = 2 using HCl at 5 °C, 
and the precipitated 5,10,15-tris(m-hydroxyphenyl)-chlorin-20-methyl benzoic acid (m-
THPC-MBA) was recovered. 









-UCNPs were dispersed in 4 mL of 
water followed by the addition of 1 mg of m-THPC-MBA in 1 mL of ethanol. The 
mixture was adjusted to neutral pH to deprotonate the carboxylic group on the m-THPC-





-UCNPs were precipitated in acetone and then isolated by 
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centrifugation at 4000 rpm for 15 min. The m-THPC-MBA has relatively high solubility 
in acetone and all the free molecules would be removed with the supernatant. 
3.3 Computational Calculations 
Calculations of the electronic absorption spectra of m-THPC and m-THPC-MBA 
were carried out using the Gaussian 09 software package on the Golem Server at 
Concordia University. 
The molecular geometries of the ground singlet state were optimized together with 
the frequency at the TD-DFT (time-dependent density functional theory) level using 
Becke’s three-parameter functional with the Lee-Yang-Parr correlation functional 
(B3LYP) with basis set 6-31G(d,p). The solvation model CPCM (conductor-like 
polarizable continuum model) was applied to stimulate the experimental environment 
using ethanol as the solvent. The method TD-DFT/B3LYP with basis set 6-31G(d,p) was 
used to calculate the absorption spectra of the geometry optimized m-THPC and three m-
THPC-MBA isomers  in liquid phase (CPCM, with ethanol as solvent). The excited state 
energies of both singlet and triplet states were calculated for 15 transitions. 
3.4 Detection of Singlet Oxygen  
The singlet oxygen generation of the photosensitizer and the nanoconstruct was 
measured using the singlet oxygen trap 1, 3-diphenylisobenzofuran (DPBF). The 
chemical trap DPBF reacts specifically with the singlet oxygen to form an endoperoxide 
upon a cycloaddition reaction as shown in Scheme 3.1. The DPBF trap is yellow in color 
and has a characteristic absorption band centered at 415 nm. Upon reaction with singlet 
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oxygen, a colorless product is formed and the decrease in absorption (415 nm) is used to 
calculation the amount of singlet oxygen generated [67, 68]. 
 
Scheme 3.1. Reaction of chemical trap DPBF (I) and singlet oxygen to form a colorless 
intermediate endoperoxide (II).  
 
The singlet oxygen generated by the photosensitizer and the nanoconstruct under 
irradiation using 435 nm and 980 nm light, was monitored using the chemical trap DPBF. 
All the measurements were performed in air-saturated propylene glycol/ethanol mixture 
solution in a 10 mm x 10 mm quartz cuvette. The total volume of solution used was 2 mL 
containing 2.5 x 10
-5 
M of DPBF and 5 x 10
-5 
M of m-THPC-MBA which corresponds to 




-UCNPs in solution. The samples were 
kept in dark at all the time except during the irradiation under excitation light. 
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3.5 In Vitro MTT Assay 





-UCNPs was analyzed by the MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-
diphenyltetrazoliumbromide) colorimetric assay in the absence and presence of 
irradiation at 980 nm. This method is based on the capacity of the dehydrogenases of 
living cells to reduce the salt of tretazolio MTT to a colored and insoluble compound, 
formazan. 





-UCNPs followed by the cells being incubated with MTT 
(0.1 mg/ml in DMEM with 10% SFB and 1% L-glutamine) for 4 hours at 37 °C. The 
medium with the MTT was removed and the crystallized formazan was suspended with 1 
ml of dimethylsulphoxide (DMSO). Immediately after, the absorbance at 540 nm was 
measured using plate reader (Espectra Fluor 4, Tecan). Cell viability was obtained as a 
percentage relative (100% viability) to the mean of absorption obtained from the control 










-UCNPs, and exposed to NIR radiation during 1 hour (using 
Hydrosun®750 irradiator with a water filter). Cell viability was also estimated as a 
percentage relative (100% viability) to the mean of absorption obtained from the control 
cells (cells incubated without nanoparticles but exposed to NIR radiation for1 hour). 
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3.6 Characterizations Techniques  
3.6.1 Fourier Transform Infrared (FTIR) Spectroscopy 









-UCNPs were measured on a Nicolet 6700 FTIR 
spectrometer by using KBr as the background. 
3.6.2 Transmission Electron Microscopy (TEM) 




 -UCNPs was 
performed using a Philips CM200 microscope operating at 200 kV equipped with a 
charge-coupled device (CCD) camera (Gatan). Prior to analysis, a sample of the 
nanoparticles was dispered in toluene to yield a 0.5 wt% solution. A few drops of the 
resulting solution were evaporated on a formvar/carbon film supported on a 300 mesh 
copper grid (3 mm in diameter). 
3.6.3 X-Ray Powder Diffraction (XRPD) 
XRPD patterns were measured using a Scintag XDS-2000 Diffractometer equipped 
with a Si(Li) Peltier-cooled solid state detector, a Cu Kα source using a generator power 
of 45 kV and 40 mA, divergent beams (2 mm and 4 mm), and receiving beam slits (0.5 
mm and 0.2 mm). The scan range was set from 10-90° 2θ with a step size of 0.02° and a 
count time of 2 s. The sample was measured using a quartz “zero background” disk. 
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3.6.4 Upconversion Luminescence Spectroscopy 





UCNPs and the Ln
3+
-UCNP-m-THCP-MBA were obtained upon 980 nm excitation, 
using a Coherent 6-pin fiber-coupled F6 series 980 nm laser diode (power of 615 mW), 
coupled to a 100 μm (core) fiber. For the upconversion studies, the samples (1 wt% in 
EtOH/propylene glycol) were placed in a Hellma, QS quartz cuvette (1 cm path length). 
The upconverted visible emissions were collected at right angle with respect to the 
incident beam and subsequently dispersed by a 1m Jarrell-Ash Czerny-Turner double 
monochromator with an optical resolution of ~0.15 nm. The emission was detected by a 
thermoelectrically cooled Hamamatsu R943-02 photomultiplier tube. A preamplifier, 
model SR440 Standard Research Systems, processed the photomultiplier signals and a 
gated photon counter model SR400 Standard Research Systems data acquisition system 
was used as an interface between the computer and the spectroscopic hardware. The 
signal was recorded under computer control using the Standard Research Systems SR465 
software data acquisition/analyzer system. 
The UV emissions were collected using a Spex Minimate ¼ m monochromator and 
detected with an Oriel 70680 photomultiplier tube. It should be noted that while the UV 
and visible emissions are measured with different detectors, they overlap in the blue 
region. Thus, by measuring the overlapping regions with both monochromators, under 




3.6.5 UV/Vis Absorption Measurement 





-UCNPs were all measured in solvent mixture propylene 
glycol/EtOH and were recorded using Varian (Mulgrave, Victoria, Australia) Cary 5 and 
5000 spectrophotometers. 
3.6.6 Mass Spectrometry 
Mass spectrometry measurements were performed using a LC-MSD TOF (Agilent) 
using ESI as the ionisation source with mass range of 50 – 8000 m/z.  
Preparative Liquid Chromatography – Mass Spectrometry (Prep LC-MS) was used 
to separate the products and m-THPC, using an MSQ Plus TM Single Quadrupole Mass 
























upconverting nanoparticles (UCNPs) and the photosensitizer 





-UCNPs that showed stronger UV/blue emission following 
NIR excitation with 980 nm light compared to NaYF4 [25], therefore these UCNPs were 
used as the platform for the nanoconstructs. 
4.1 Morphology and Size 
The thermal decomposition synthesis was used to produce the lanthanide-doped 




to be used as the excitation 





showed a diamond-like morphology with an average size of 86 nm long diagonal length 
with an aspect ratio of 1.7. The transmission electron microscopy (TEM) results and size 









-UCNPs (5 wt% in toluene) 





4.2 Crystal Phase 
From the high-resolution TEM image, Figure 4.2, the distance between the lattice 
fringe was measured to be 4.6 Å which corresponds to the d-spacing for the (101) planes 
in the tetragonal LiYF4 structure. 
 
Figure 4.2. High resolution TEM image showing the lattice arrangement of the atoms in 
the crystals. The distance between the adjacent planes (d-spacing) was measured to be 4.6 









-UCNPs and the calculated standard JCPDS pattern. The peak positions 
correspond closely to the reported pattern of tetragonal LiYF4 (JCPDS No. 81-2254). The 
corresponding hkl planes are shown for each peak indexed.  
 





-UCNPs showing the tetragonal crystal phase. 
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 4.3 Surface Characterization 
Figure 4.4(i) shows the FT-IR spectra of the oleate capped UCNPs. The spectrum 
clearly shows that the oleate capping ligands are present on the surface of the 
nanoparticles. The peaks at 2933 cm
-1
 and 2857 cm
-1
 originate from asymmetric and 
symmetric stretching of –CH2 groups, and the peaks located at 1568 cm
-1
 and 1468 cm
-1
 
can be assigned to the asymmetric (as) and the symmetric (s) –COO
-
 stretches 
respectively. For comparison we have included the spectrum of oleic acid (Figure 4.4 
(iii)) It is worth noting that the band at 1710 cm
-1
 in the FT-IR spectrum of oleic acid 
corresponds to the C=O which is absent in the oleate capped nanoparticles. We conclude 
that for the oleate capped Ln-UCNPs the oleic acid molecules are chemically adsorbed on 
the Ln-UCNP through the coordination by the COO
-
 group of the Ln
3+
 ions on the 
surface. This has been observed previously for oleate capped NaYF4 nanoaparticles [66]. 
 









-UCNPs; and (—) oleic acid. 
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4.4 Upconversion Spectroscopy 
The UV, visible, and NIR upconversion emission spectrum of a 0.5 wt% solution of 




 25 mol% in toluene upon irradiation with 
980 nm light is shown in Figure 4.5. In the UV region two strong emission bands at 353 












H6 respectively.  In the visible region, two blue emissions 
bands centered at 450 and 480 nm and a red emission at 650 nm are observed. These 












F4 transitions respectively. In the 




H6 is observed. This emission band could be used in biomedical applications such 
as in bioimaging. 




 is shown in Figure 4.6 and has 
been reported previously by our group [25]. It is important to mention here the fact that 
the UV emissions require several incident photons (NIR) suggesting that LiYF4 is an 
efficient matrix at the nanoscale, compared to other fluorides or oxides matrices for Ln
3+
 
doping, in particular for Tm
3+
 ions. For example, the emission at 290 nm requires at least 
five incident photons to populate the 
3
P0 emitting level, which is not observed when the 
Tm
3+
 ions are doped in the much studied NaYF4 matrix or other Tm
3+
 doped 
nanoparticles. This supports the conclusion that LiYF4 is an efficient matrix for 
upconversion. 
To reduce the cross-relaxation energy loss in the upconversion, the concentration of 
Tm
3+
 ions are generally kept very low, 0.5 mol% in this case, so that all the Tm
3+ 
ions 
could be isolated in the nanoparticles and no energy
 
would be transferred among them. 
 45 
 
Unlike the activator, the sensitizer is usually present in a higher concentration in the 
nanoparticles. Yb
3+
 ions are good sensitizers due to the large absorption cross-section in 




F5/2 transition (Figure 4.6), which is also 
resonance with the f-f transition of Tm
3+





 in the upconversion process. 
 










Figure 4.6. Schematic representation of the possible energy transfer processes 















Chapter Five – Modification and Characterization of the Novel 
Photosensitizers m-THPC-MBA 
The photosensitizer Temoporfin (5,10,15,20-tetra(m-hydroxyphenyl) chlorin, m-
THPC, or Foscan®) is a commercially available drug widely used in the treatment of 
head and neck cancers. As a second generation photosensitizer it has an enhanced 
absorption of light in the red that has been found to be more effective than conventional 
porphyrins and reduces the skin photosensitization which is a side effect associated with 
PDT. The absorption of photosensitizers is an essential aspect to consider in the 
development of PDT and the work present in this thesis aimed to use the NIR light as the 





-UCNPs, so that the photodynamic therapy 
can be applied in “deep” tissues. To facilitate the conjugation with upconverting 
nanoparticles, the photosensitizer m-THPC needed a modification which facilitates the 
conjugation of m-THPC to the nanoparticles and give rise to a shift of the Soret band in 
order to maximize the overlap of this band with the blue emission band of the UCNPs. 
Computational studies were carried out to ascertain the position of the linker and the 
effect on the absorption spectrum of m-THPC. 










5.1 Modification of the Photosensitizer   
The photosensitizer m-THPC is a porphyrin derivative that has a macrocycle ring 
with four phenoxyl groups attached in the meso positions. The structure shows that m-
THPC lacks appropriate functional group(s), which would allow it to be conjugated to the 
UCNPs. In addition, the as-synthesized UCNPs are capped with oleate, which does not 
react with the photosensitizer. In order to conjugate m-THPC to the UCNPs both must be 
modified. An acid treatment developed in our laboratory to remove the oleate ligand from 
their surface (see Chapter 4) was employed, which facilitates the direct conjugation of 
electronegative groups rendering the UCNPs amenable to m-THPC functionalization 
[66]. In addition, the m-THPC required modification to introduce an appropriate 
negatively charged group to bond to the ligand-free UCNPs positively-charged surface. In 
order to modify the m-THPC, 4-(bromomethyl)benzoic acid (BMBA) was used as it is a 
commonly used “linker” in biological applications that is generally recognized as non-
harmful to tissues and organs and provides the required carboxylate functionality (-COO-
) to bond to the surface of the nanoparticles.  
The methyl benzoic acid (MBA) linker was covalently bonded to the m-THPC using 
the coupling reaction shown in Scheme 5.1. In the reaction the strong base NaH, having 
H2 as its conjugate acid with a pKa of 35,0 was employed to deprotonate the phenol (pKa 
10) and amine (pKa 17.5) groups of m-THPC. Deprotonation renders m-THPC 
nucleophilic which favors the substitution reaction with 4-(bromomethyl)benzoic acid to 
produce three possible products m-THPC-MBA (I), m-THPC-MBA (II), and m-THPC-
MBA (III). Therefore, it is important to ascertain the number and position of the linkers. 
The two isomers m-THPC-MBA (I) and m-THPC-MBA (II) have linker on the phenyl 
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group “outside” the chlorin whereas for m-THPC-MBA (III) the linker is shown as being 
added to the nitrogen in the chlorin ring. Scheme 5.2 shows the mechanism, which could 
lead to the deprotonation of the pyrrole followed by a nucleophilic attack of the linker to 
form m-THPC-MBA (III). It should be noted that m-THPC possesses a plane of 
symmetry (Scheme 5.1) therefore the substitutions that occur on the left side of m-THPC 
are equivalent to those on the right side, thus resulting in only three possible isomers.  
 
Scheme 5.1. Conversion of m-THPC to m-THPC-MBA (I), (II), and (III) endowing a 
carboxylic acid functionality to the latter and allowing for the molecule to cap the 








Scheme 5.2 Deprotonation of pyrrole group using sodium hydride followed by 
substitution reaction. 
5.1.1 Absorption Spectroscopy of the Modified Photosensitizer 
The coupling reaction of m-THPC and 4-(bromomethyl)benzoic acid produced a 
green colored product. UV/Vis spectra of m-THPC and of the product m-THPC-MBA 
shown in Figure 5.1 were carried out in an ethanol/propylene glycol mixture, which is the 
solvent suggested by the European Medicines Evaluation Agency (EMEA) to be used for 
the injection of m-THPC in humans. A comparison between the spectrum of the 
unsubstituted parent and the product (m-THPC-MBA) showed three distinct differences, 
namely a red shift of the Soret band from 417 nm (parent) to 438 nm (green product), a 






), peak broadening and 
the disappearance of two of the Q-bands in the 500 nm region and of the peak at 650 nm.  
The number of linkers and their position(s) bonding to the m-THPC was expected to 
shed light on the possible reasons for the observed spectral difference. In the following 
sections experimental and computational results are presented and discussed to explain 





Figure 5.1. UV/Vis spectra of (—) m-THPC and (—) the m-THPC-MBA product (green 
color) measured in an ethanol/propylene glycol mixture solvent. 
5.1.2 Isolation and Characterization of m-THPC-MBA 
The product from the coupling reaction may be a mixture as postulated in Section 
5.1. Thus it was necessary to ascertain the number and the position of the "linker(s)" 
bonding to the m-THPC. The number of linkers bonded to m-THPC was investigated 
using liquid-chromatography mass spectroscopy (LC-MS) and the results (Figure 5.2) 
showed the product is a mixture consisting of three different compounds with 1 to 3 
methyl benzoic acids bonded to m-THPC. Using centrifugal thin-layer chromatography it 
was found that the major product (58% of the total) has one linker bonded to m-THPC 
and the two minor products, which constitute 15% and 11% of the total and have two and 
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three "linkers" respectively bonded to m-THPC. The rest 16% is the unreacted reagent m-
THPC.   
The major product was isolated and characterized by LC-MS and showed two main 
peaks, having a molecular ion peak at 815, which corresponds to only one linker bonded 
to m-THPC. To isolate these two isomers further purification was carried out using 
preparative liquid chromatography using a reversed phase column and characterized by 
mass spectrometry. The elution profile (Figure 5.3) of the products with molecular ion 
peaks at 815 showed two main bands with retention times of 7.5 min and 10.1 min, 
indicating the presence of at least two isomers with different structure.    
 
Figure 5.2. LC-MS results of the products from the coupling reaction. The spectrum 
shows four compounds; (a) m-THPC, (b) m-THPC-MBA with one linker, (c) m-THPC-




Figure 5.3. Elution profile from Prep LC-MS. Isomers m-THPC-MBA (I) and (II) with 
molecular weight of 815 were eluted at retention time 10.1 min, and isomer m-THPC-
MBA (III) was eluted at 7.5 min. 
 
UV/Vis absorption spectra of the two eluted fractions were measured in a solution of 
ethanol/propylene glycol and compared to the spectrum of m-THPC. The resulting 
spectra are shown in Figure 5.4. The fraction that has an elution time of 10.1 min 
demonstrated excellent correspondence with the absorption spectrum of the m-THPC, 
whereas the fraction with an elution time of 7.5 min showed a red shift in comparison to 
m-THPC. 
 Three possibilities may be put forward to explain the red shift. Firstly, the addition 
of methyl benzoic acid to m-THPC serves as an electron-donating group, which changes 
the electron distribution of the porphyrin. Increasing the electron density lowers the 
energy gap between the ground and excited state resulting in absorption at the longer 
wavelength. Secondly, the observed changes may be due to the aggregation of the m-
THPC molecules that has been reported previously [69]. m-THPC molecules are 
hydrophobic and tend to aggregate in polar solvents or in an aqueous environment. The 
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aggregation of m-THPC has been attributed to hydrogen bonding of the peripheral phenyl 
groups of the m-THPC molecules. This results in a chain like structure (J-type) that is 
characterized by a large offset between the line connecting the centres and the direction 
of the transition dipoles in two neighbouring molecules. However, aggregation can be 
eliminated as the cause for the red shift since it has been shown to occur when the 
concentration of m-THPC exceeds 10
-4 
M in ethanol or the solvent contains more than 
50% volume ratio of water [70, 71]. The experiments in this study were carried out at a 
concentration of 10
-5
 M m-THPC in an ethanol/propylene glycol mixture. Thirdly, at the 
pH of the medium (pH lower than the pKa of the imino groups: pK3=3.45 and pK4=1.45), 
the nitrogens are protonated and thus the m-THPC molecules will be positively charged 
resulting in an observed red shift [69]. However, since all the experiments were 
performed using the physiological pH of 7.4, the pH of the medium is not a plausible 
explanation for the observed red shift. At this point we postulate that the red shift of the 
Soret band in the absorption spectrum of m-THPC-MBA (III) is strictly due to the 






Figure 5.4. UV/Vis absorption spectra of (—) m-THPC, (—) m-THPC-MBA (I) and (II) 
isomers eluted at 10.1 min and (—) m-THPC-MBA (III) isomers eluted at 7.5 min from 
Prep LC-MS. All three spectra were measured in ethanol/propylene glycol mixture 
solvent. 
5.2 Computational Studies of m-THPC and m-THPC-MBA 
It has been well documented that changes in the conjugation pathway and symmetry 
of porphyrin can affect its UV/Vis absorption spectrum. The absorption spectrum of 
porphyrin has long been understood in terms of the highly successful four orbital model 
first applied by Gouterman [59, 60]. The method demonstrated the importance of charge 
localization on electronic spectroscopic properties and the absorption bands of porphyrin 
all arise from the transitions between two HOMOs and two LUMOs. It is well recognized 
that time dependent density functional theory (TD-DFT) methods can be used 
successfully to study the electronic structure and spectral properties of porphyrin and 
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related compounds [57, 58]. Thus, to understand the observed spectral changes (effect of 
substituent and its position) such as red shift of Soret band on the modified m-THPC-
MBA, a computational study was carried out using Gaussian 09 program [72]. In the 
calculations time-dependent density functional theory (TD-DFT) was combined with 
Becke Three Parameter Hybrid Functionals (B3LYP) and the basis set 6-31G(d,p) was 
used to optimize the ground state geometry of the four of the m-THPC and m-THPC-
MBA as well as to simulate the absorption spectra [73, 74]. The solvent effect of ethanol 
was simulated using the CPCM (conductor-like polarizable continuum model) [75, 76]. 
The models used, m-THPC-MBA (I), m-THPC-MBA (II), m-THPC-MBA (III), shown in 
Scheme 5.1 are based on the possible reactive sites of m-THPC. 
 5.2.1 Molecular Structure via Geometry Optimization  
In computational analysis it is imperative to perform geometry optimization on the 
molecules of interest before carrying out any other calculations since structural changes 
of a molecule could lead to changes in its energy and other properties. The ground state 
geometry of m-THPC and the three modified m-THPC-MBA isomers were optimized 
and their optimized geometries were verified to be local minima by frequency 
calculations.  The calculations from all four models show that the chlorin macrocycle is 
planar and the four phenyl groups at positions 5, 10, 15, 20 do not lie planar to the chorin 
macrocycle, but are positioned in ~60° angle (Figure 5.5). It has been previously shown 
that this geometrical arrangement of the phenyl groups is responsible for only a minor 




Figure 5.5. The ground-state molecular structures of (a) m-THPC, (b) m-THPC-MBA 
(I), (c) m-THPC-MBA (II), and (d) m-THPC-MBA (III) optimized at the TD-
DFT/B3LYP level. The red dash line passing through the two pyrroles (----) represents 
the yz-plane of symmetry. 
 
For the modified m-THPC-MBA (I) and m-THPC-MBA (II) where the methyl-
benzoic acid linker is added to the phenyl groups at positions 5 and 20 respectively, the 
linker is at an angle of ~27° from the xy-plane and parallel to the chlorin macrocycle as 
indicated in Figure 5.6. For m-THPC-MBA (III) where the linker has added to the 
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nitrogen in the chlorin ring, it was found to be at an angle of 67° to the chlorin 
macrocycle. More importantly, the two nitrogen atoms of the pyrrole move upwards from 
the xy-plane and as a consequence the chlorin ring is distorted and thus the symmetry of 
the macrocycle is broken. 
 
Figure 5.6. The structures of the ground state viewed from the y-axis showing the side-
view of the geometry. Three of the molecules (a, b, c) have a planar chlorin ring while in 




5.2.2 Computational Studies of Excited State Electronic Structure and Absorption 
Spectroscopy   
The chlorin macrocycle is the reduced form of porphyrin with a saturated bond 
between C17 and C18. Gouterman's four orbital model was applied to calculate the 
absorption spectra of m-THPC and of the three isomers of m-THPC-MBA. The four 
orbital model has shown that the absorption bands of chlorin arise from transitions 
between two HOMOs and two LUMOs. The energies associated within these orbitals are 
very important factors that influence the transitions thus the resulting absorption spectra. 
Figure 5.7 shows the calculated four molecular orbitals from HOMO -1 to LUMO +1 for 
m-THPC and the three isomers. The calculated molecular orbitals of the chlorin ring 
show no difference between m-THPC, m-THPC-MBA (I), and m-THPC-MBA (II). 
Whereas for m-THPC-MBA (III) the π-orbitals between carbon 10 and 11 (in HOMO-1) 
and between carbon 8 and 9 (in HOMO) have a larger volume compared with the same 
orbitals for m-THPC and m-THPC-MBA (I) and m-THPC-MBA (II). The changes in the 
molecular orbitals are reflected in their energies as illustrated in the partial molecular 




Figure 5.7. Calculated molecular orbitals (from bottom to top, HOMO -1 through LUMO 
+1) for (a) m-THPC, (b) m-THPC-MBA (I), (c) m-THPC-MBA (II), and (d) m-THPC-
MBA (III). The electron density is shown as the balloons in red (positive wavefunction) 




Figure 5.8. Partial molecular orbital diagrams from HOMO -1 to LUMO +1 of m-THPC, 
m-THPC-MBA (I), m-THPC-MBA (II) and m-THPC-MBA (III) calculated by TD-DFT 
in liquid phase using CPCM solvation model. 
 
Transitions between two HOMOs and two LUMOs give rise to two excited states 
and orbital mixing splits these two states producing a higher energy state with a higher 
oscillator strength (Soret band) and a lower energy state with lower oscillator strength 
(Q-bands). In case of chlorin system the absorption bands are mainly due to the lowest 
four excited singlet states from S1 to S4. A total of 15 transitions were used to calculate 
the absorption spectra for m-THPC and the three isomers m-THPC-MBA.  As shown in 




 excited singlet state, respectively, are for 
the transitions between HOMOs and LUMOs in which the dipole moments are in the 
same direction, therefore resulting in higher energy and intensity. The Q-bands Q1 and Q2 
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correspond to the excitations from the ground singlet state to the first and second excited 
singlet states. Since the transitions between HOMOs and LUMOs that generate the two 
Q-bands have dipole moments with opposite direction, these transitions show are much 
weaker and at lower energy. In Table 5.1 the calculated excitation energies and the 
oscillator strengths of m-THPC and three m-THPC-MBA isomers are summarized. The 
results reveal a bathochromic shift in the Soret band of the m-THPC-MBA (III) 









Figure 5.9. The simulated absorption spectra and excited state diagram of m-THPC, m-
THPC-MBA (I), m-THPC-MBA (II), and m-THPC-MBA (III). The 15 transitions 











Table 5.1 Calculated excitation energies and oscillator strengths of m-THPC, m-THPC-










S1 572.11 2.1671 0.1360 
S2 530.75 2.3360 0.0727 
S3 408.05 3.0384 1.1918 
S4 398.47 3.1115 1.5092 




S1 572.66 2.1651 0.1292 
S2 532.57 2.3280 0.0838 
S3 409.29 3.0292 1.2229 
S4 399.56 3.1030 1.5805 





S1 573.01 2.1637 0.1293 
S2 533.12 2.3256 0.0853 
S3 409.83 3.0253 1.2347 
S4 399.83 3.1009 1.5605 






S1 593.73 2.0882 0.0937 
S2 564.90 2.1948 0.1863 
S3 432.71 2.8653 1.1580 
S4 417.85 2.9672 1.0851 
T1 1005.58 1.2330 n/a 
  
The calculated electronic absorption spectra (in ethanol) of the three isomers and m-
THPC are shown in Figure 5.10. There is an excellent overlap between the calculated 
absorption spectra of m-THPC, m-THPC-MBA (I) and m-THPC-MBA (II). More 
importantly the calculated absorption spectrum of m-THPC-MBA (III) shows a 
bathochromic shift of the Soret band which is in excellent agreement with the 
experimental absorption spectrum. The linker MBA is an electron donor thus we would 
expect a change in electron density in the temoporfin molecule, which may affect the 
absorption spectrum. However, the simulation results for the two isomers m-THPC-MBA 
(I, II) clearly show that the addition of MBA has no effect on the absorption properties. 
The linker is 6.16 Å from the chlorin ring, in addition there is an isolating group, -CH2-, 
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between the carboxyphenyl and the phenyl ring, therefore the linker is not conjugated to 
the chlorin ring and has no influence on the absorption properties. In contrast, the 
addition of the linker on the nitrogen in the chlorin ring results in a bathochromic shift of 
the Soret band. In this case the proximity of methyl benzoic acid to the conjugated system 
increases the electron density resulting in a decrease of the energy gaps between the 
HOMO and the LUMO, which manifests itself as a red shift of the Soret band. The 
distortion of the chlorin ring caused by the addition of the MBA may also contribute to 
the bathochromic shift. The computational results have allowed us to determine m-
THPC-MBA (III) to be the product isolated, which is responsible for the red shift of the 
Soret band from 417 nm to 438 nm.  
 
Figure 5.10. The simulated absorption spectra of (—) m-THPC, (—) m-THPC-MBA (I), 
(—) m-THPC-MBA (II) and (—) m-THPC-MBA (III) calculated by TD-DFT/B3LYP in 
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ethanol using CPCM solvation. The spectra of m-THPC-MBA (I) and m-THPC-MBA 
(II) are indeed overlapped. 
5.3 Calculation of the Triplet Excited State of m-THPC and m-THPC-MBA Isomers 
A good photosensitizer must be able to generate singlet oxygen. This is determined 
by the energy of the excited triplet state T1. The singlet excited state may decay to the 
ground state via spin inversion and populate the T1 through intersystem crossing (ISC). 
The energy gap between the ground singlet state G and the excited triplet state T1 must be 
larger than 0.98 eV in order to excite oxygen from its ground triplet state to the first 
singlet state 
1Δg [32]. Using TD-DFT/B3LYP methods the 1
st
 triplet state excitation 
energies of m-THPC and m-THPC-MBA isomers were calculated and are summarized in 
Table 5.2.  
 
Table 5.2 Energies of the ground singlet state and the difference between the ground 
singlet state and the first excited triplet state optimized with various methods.  
Compound Ground Singlet State (eV) TD-DFT/B3LPY 
CPCM Gas 
m-THPC -0.2747 1.68 1.66 
m-THPC-MBA(I) -0.3316 1.73 1.72 
m-THPC-MBA(II) -0.3316 1.56 1.56 
m-THPC-MBA(III) -0.3316 1.73 1.72 
 
The calculations were performed in both gas phase and liquid phase (ethanol) using 
CPCM. The excited triplet energies in both phases showed very similar results and were 
all higher than the required 0.98 eV. Therefore, the computational results show that 
adding the linker on the chlorin ring via the nitrogen atom does not affect the 










The modified photosensitizer m-THPC-MBA (III) which shows the red shift of the 










-UCNPs possess a positive charges on their surface and the carboxylate 
group of the photosensitizer m-THPC-MBA (III) has a negative charges. The resulting 
nanoconstruct (m-THPC-MBA (III)-UCNP) showed a green color, had very good 
dispersibility in ethanol/propylene glycol solution and it is stable for months. It was 
found there are 7.6 x 10
3
 molecules of m-THPC-MBA (III) on each UCNP. A schematic 
illustration of the nanoconstruct is shown in Figure 6.1. 
 





 nanoparticles and photosensitizer m-THPC-MBA(III). The diamond 
represents the surface of the nanoparticle: purple spheres = F
-





, and blue spheres = Tm
3+
. The carboxylate from m-THPC-MBA(III) is 
coordinated to the Y
3+
 ions of the Ln
3+
-UCNP via electrostatic interaction. 
 68 
 
6.1 Transfer of Energy between Nanoparticles and Photosensitizers 




-UCNPs and the UV/Vis 
absorption spectrum of m-THPC-MBA (III) are shown in Figure 6.2. There are two 
important conditions necessary for fluorescence resonant energy transfer (FRET) to occur 
between the UCNPs (donor) and the m-THPC-MBA (III) (acceptor): there must be 
overlap in the absorption (acceptor) and emission peaks (donor) shown in Figure 6.2 and 
the distance between the donor and acceptor should be shorter than 10 nm [78].  
 
Figure 6.2. Overlap of (—) the absorption spectrum of m-THPC-MBA and (—) the 




-UCNPs. The energy transfer 















are shown in Figure 6.3. We observe a decrease in the 










The spectra were normalized with respect to the NIR emission peak at 800 nm and 









-UCNPs was found to 
be 3:2. This indicates that the binding of m-THPC-MBA on the UCNPs resulted in the 
quenching of the emission of the blue peaks, which clearly demonstrates that resonance 




-UCNPs to the m-THPC-MBA(III) is 
occurring. The energy transfer efficiency was calculated using the following equation 
[79], 
E = 1 – I1/I2    (14) 










-UCNPs at in the same region. The energy transfer 
efficiency was calculated to be ~33%. This result also confirms that the spatial 
separation, which was calculated to be 6.16 Å between the donor and the acceptor 






Figure 6.3. Upconverting emission spectra demonstrating the energy transfer between the 
Ln
3+
-UCNPs and photosensitizer. A decrease of intensity was observed in the blue region 










6.2 Generation of Singlet Oxygen by m-THPC-MBA(III)  
The generation of 
1
O2 is primordial in photodynamic therapy, thus we initially 
assessed its production by the modified photosensitizer, m-THPC-MBA(III), under 435 
nm (maximum absorption of m-THPC-MBA(III)) excitation (Figure 6.5) using the 
standard reaction of 1, 3-diphenylisobenzofuran (DPBF) with singlet oxygen. Figure 6.4 
shows the absorption spectrum of DPBF and the cycloaddition reaction of singlet oxygen 
with the chemical trap. Upon cycloaddition with singlet oxygen, DPBF is known to form 
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an intermediate endoperoxode whose final degradation product no longer absorbs at 415 
nm [67, 68]. A solution of DPBF (2.5 x 10
-5
 M) and m-THPC-MBA(III) (5 x 10
-5 
M) in 
propylene glycol/ethanol was exposed to a filtered light source of wavelength 435 nm 
over a period of 0 to 45 s at intervals of 5 s. Figure 6.5 shows the decrease in absorbance 
of DPBF at 415 nm as a function of radiation time.  The absorbance of the trap reaches 
approximately zero after an irradiation time of 45 s, which demonstrates that the 
introduction of the electron donating group (MBA) as assessed by the generation of 
singlet oxygen.  
 
Figure 6.4. UV/Vis absorption spectrum of DPBF in ethanol/propylene glycol mixture 
solvent. Inset: 1,4-cycloaddition reaction between the singlet oxygen and DPBF that 





Figure 6.5. Decrease in the absorption of DPBF in a DPBF (2.5 x 10
-5
 M)/m-THPC-
MBA (III) (5 x 10
-5 
M) solution as a function of irradiation time using 435 nm light. 
6.3 Generation of Singlet Oxygen by the Nanoconstruct, m-THPC-MBA(III)-UCNP  





-UCNPs and to assess their potential to generate singlet 
oxygen under 980 nm excitation.  







UCNPs (1 mg/mL which correspond to 5 x 10
-5 
M) in an ethanol/propylene glycol 
mixture was exposed to an irradiation source of 980 nm over a period of 120 min at 10 
minute intervals. Figure 6.6 shows the decrease in absorbance of DPBF at 415 nm as a 
function of irradiation time, which indicates that the amount of singlet oxygen production 
increases. The concentration of singlet oxygen generated was calculated from the 
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consumption of DPBF and it was found to be 2.11 x 10
-5
 M. The nanoconstruct has been 
shown to generate singlet oxygen for an irradiation time of 2 hours, which is the normal 
length for a PDT treatment, this suggests that the nanoconstruct could be a promising 
photosensitizer for the PDT. 
 
Figure 6.6. Decrease in the absorption of DPBF in a DPBF (2.5 x 10
-5
 M)/m-THPC-
MBA-UCNPs (1 mg/mL) dispersion as a function of NIR irradiation time (min). 
6.4 In Vitro Cell Viability Tests Showing the Applicability of Nanoconstruct in PDT 
via MTT Assay  
The last part of our study the potential of the nanoconstruct as novel PDT agent was 
examined by studying in vitro cell viability in the absence and presence of irradiation at 







-UCNPs) at concentrations of 0.004 to 0.1 mg/mL in 
PBS. Cell viability was assayed using the MTT assay, a method based on the activity of 
mitochondrial dehydrogenase [26].
 
The nanoconstruct demonstrated no intrinsic toxicity 
towards the cells when not irradiated as the cellular survival rate was identical to the 
control (Figure 6.7). The relative cell viability was obtained by comparing the survival 
rate of the sample that had been incubated with the nanoconstruct with cells that had not 
incubated with the nanoconstruct (the control sample). To assess the efficacy of the 
photodynamic effect, HeLa cells were incubated for 4 hours with the nanoconstruct at the 
same concentration as stated above, which represents a concentration of 0.10 to 2.50 µM 
of m-THPC-MBA(III) and irradiated for 1 hour using NIR radiation (980 nm). Cell death 
was observed from a minimum of 20% to a maximum of 70% in the concentration range 
0.50 to 2.50 µM m-THPC-MBA (III) (Figure 6.7). Such a significant cell death 
demonstrates the possible applicability of the nanoconstructs in photodynamic therapy 













-UCNPs nanoconstructs and in the presence and absence of 





-UCNPs construct while the top axis shows the 









Chapter Seven - Conclusions 
The photo-triggered treatment tool, photodynamic therapy can efficiently kill tumor 
cells by activating photosensitizers to generate reactive oxygen species 
1
O2 under 
irradiation. However, conventional photodynamic therapy methods use visible or UV as 
the light source, which may achieve limited treatment efficacy on deep-seated tumors due 
to the low penetration depth. In view, of the advantages offered by nanoparticles, more 
specifically Ln
3+
 upconverting nanoparticles in this thesis we have addressed the 
challenge of utilizing the novel NIR-to-visible photodynamic therapy based on 
upconverting nanoparticles functionalized with a photosensitizer.  





 (25 mol%) nanoparticles. The synthesis 
successfully yields colloidal monodispersible nanoparticles with a diamond-like 
morphology, with an average size of 85 nm along the long diagonal with an aspect ratio 
of 1.7.  These nanoparticles have a tetragonal crystal structure and show intense emission 
in the UV and visible region upon excitation with 980 nm light. The as-synthesized 
nanoparticles are hydrophobic therefore a surface modification was carried out to remove 
the hydrophobic ligand oleic acid, which not only result in aqueous dispersibility but also 
a positively charged surface that facilitates the conjugation of a negatively charged 
photosensitizers.   
The second generation photosensitizer m-THPC with enhanced absorption of light at 
652 nm does not make use of the optimal biological window in the 700-100 nm range. 
The approach employed in this work to make use of the optimal optical window differs 
significantly previous reports. The approach used in this work is based on modifying the 
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m-THPC using 4-(bromomethyl)benzoic acid (BMBA) to produce m-THPC-MBA(III) 





UCNPs. In addition, this modification induces a bathochromic shift of the Soret band of 





-UCNPs. The modification reaction of m-THPC produces three isomers 
which were isolated and characterized using LC-MS. Computational results allowed us to 
determine that the m-THPC-MBA(III) among the products isolated, which is responsible 
for the red shift of the Soret band from 417 nm to 438 nm, and ascertain that the linker is 
bonded to the nitrogen of the pyrrole ring. 





980 nm to produce 
1
O2. This demonstrates that the m-THPC-MBA molecules on the 




-UCNPs are excited via an energy transfer process and 
are capable of performing PDT. More importantly, using an irradiation wavelength of 
980 nm would enable PDT in “deep” tissue. We also demonstrated that the nanoconstruct 
was capable of causing HeLa cell death up to 70% under 980 nm irradiation for a period 
of 1 hour. The general method reported can be applied to other drugs for the preparation 









Chapter Eight - Future Work 
Practical applications of UCNPs set demanding requirements on their optical 
properties, size and shape, surface chemistry, and clinical prospects, as well as their 
ability to incorporate a number of imaging and therapy modalities to achieve more 
accurate diagnostics and more effective therapeutics. In this chapter we would like to 
highlight future directions to be considered that could produce significant effects in the 
field. 




-UCNPs and in general of upconverting 







. The principle reason for this is the low quantum yield. Modification of the local 
environment around the lanthanide ions could be a promising avenue. However, the 
lanthanide ions possess low extinction coefficients, which is an intrinsic feature of f-f 
transitions. Therefore, coupling the UCNPs with quantum dots, plasmons, dyes or other 
doping ions with high absorption coefficients could provide an antenna effect similar to 
what has been used for lanthanide complexes to increase their efficiency.  
The common excitation wavelength that is used is 980 nm. This wavelength 
overlaps with the absorption of water that may cause heating in biological tissues. Thus, 
shifting the wavelength to 800 nm would be an attractive option. The Nd
3+
 ion may be 




-UCNPs have relatively large size of ~85 nm in 
the long diagonal and the sharp edges a result of their diamond morphology. This could 
inhibit their entry into cells. To maintain high emission efficiency and at the same time 
decrease their size, a core-shell structure should be used. The shell would protect the core 







 as the core and NaGdF4:Nd
3+
 as the shell.  In addition, it has been 
shown recently that the size and morphology (spherical, hexagonal) of NaGdF4 may be 
using the thermal decomposition method.  
The majority of available photosensitizer on the market are porphyrin derivatives 
that have a Soret band (high absorption coefficient) and relative weak Q-bands. The ideal 
photosensitizer for the synthesis of more efficient nanoconstruct such as the one proposed 
in this thesis require that the overlap between the Soret band and the emission of the 
UCNPs be maximized in order to obtain highly efficient energy transfer. In addition, 
photosensitizers should be synthesised which have higher absorption coefficient in the 
Soret band so that more efficient energy transfer may be achieved. Modification of m-
THPC or other similar photosensitizers using an efficient electron donating group to shift 
the Soret band towards a lower wavelength would enable the use of the Tm
3+ 
emission in 
the UV region which would result in more efficient energy transfer.  
Using the platform developed multimodal UCNPs involving optical imaging, 
Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), and X-ray 
Computed Tomography (CT) may be emerging as a new set of theranostic nanoprobes 
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